Bioprosthetic valve endocarditis: factors affecting bad outcome.
J Cardiovasc Surg (Torino)
; 32(6): 800-6, 1991.
Article
em En
| MEDLINE
| ID: mdl-1752903
ABSTRACT
Prosthetic valve endocarditis (PVE) remains an uncommon but serious complication of cardiac valve replacement. We analysed several risk factors (active or healed, early or late endocarditis, congestive heart failure, arterial emboli etc.) in order to identify the factors which may predict bad outcome. The overall mortality rate was 46.8% (15/32 patients). There was a significantly higher mortality rate in patients with early endocarditis (80%) than in those with late endocarditis (38%) (p less than 0.01). In the group of patients who underwent reoperation, the mortality rate was higher in those with active endocarditis (70%) than in those with healed endocarditis (28.5%) (p less than 0.05). We believe that combined medical and surgical treatment is the best management for bioprosthetic valve endocarditis, with the institution of appropriate preoperative antibiotic therapy, to attempt to achieve sterilization.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Bioprótese
/
Próteses Valvulares Cardíacas
/
Infecções Relacionadas à Prótese
/
Endocardite Bacteriana
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Cardiovasc Surg (Torino)
Ano de publicação:
1991
Tipo de documento:
Article
País de afiliação:
Itália